 Dae Won Park
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 8 | 2018 | 479 | 2.230 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2022 | 528 | 1.680 |
Why?
| | Biomimetic Materials | 4 | 2017 | 70 | 1.470 |
Why?
| | Tissue Scaffolds | 5 | 2019 | 203 | 1.380 |
Why?
| | Gels | 3 | 2020 | 83 | 1.080 |
Why?
| | Delayed-Action Preparations | 3 | 2018 | 174 | 1.050 |
Why?
| | Polyurethanes | 2 | 2015 | 38 | 0.880 |
Why?
| | Hydrogels | 5 | 2022 | 646 | 0.850 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 176 | 0.730 |
Why?
| | Anti-Bacterial Agents | 3 | 2018 | 1708 | 0.730 |
Why?
| | Acrylamides | 2 | 2018 | 57 | 0.690 |
Why?
| | Temperature | 2 | 2014 | 635 | 0.690 |
Why?
| | Drug Delivery Systems | 2 | 2014 | 337 | 0.690 |
Why?
| | Tissue Engineering | 4 | 2019 | 401 | 0.670 |
Why?
| | Materials Testing | 4 | 2019 | 349 | 0.640 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 24 | 0.600 |
Why?
| | Sulfones | 1 | 2018 | 108 | 0.570 |
Why?
| | Neurites | 2 | 2016 | 47 | 0.550 |
Why?
| | Nerve Regeneration | 2 | 2016 | 62 | 0.550 |
Why?
| | Spina Bifida Cystica | 1 | 2017 | 2 | 0.550 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2018 | 175 | 0.520 |
Why?
| | Biocompatible Materials | 2 | 2018 | 404 | 0.520 |
Why?
| | Amniotic Fluid | 1 | 2017 | 87 | 0.520 |
Why?
| | Myocardium | 2 | 2019 | 983 | 0.510 |
Why?
| | Air Filters | 1 | 2015 | 2 | 0.500 |
Why?
| | Myocardial Infarction | 2 | 2022 | 1021 | 0.490 |
Why?
| | Retinal Ganglion Cells | 1 | 2016 | 101 | 0.490 |
Why?
| | Acrylic Resins | 2 | 2018 | 44 | 0.480 |
Why?
| | Meningomyelocele | 3 | 2021 | 56 | 0.480 |
Why?
| | Stroke Volume | 1 | 2018 | 593 | 0.470 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 259 | 0.460 |
Why?
| | Biodegradable Plastics | 1 | 2014 | 3 | 0.460 |
Why?
| | Micelles | 1 | 2014 | 37 | 0.450 |
Why?
| | Triamcinolone Acetonide | 1 | 2014 | 27 | 0.450 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 63 | 0.450 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 444 | 0.440 |
Why?
| | Neurogenesis | 1 | 2015 | 126 | 0.430 |
Why?
| | Neural Stem Cells | 1 | 2015 | 142 | 0.420 |
Why?
| | Heparin | 1 | 2014 | 254 | 0.410 |
Why?
| | Heart Ventricles | 1 | 2018 | 781 | 0.410 |
Why?
| | Motor Neurons | 1 | 2015 | 233 | 0.400 |
Why?
| | Silicon Dioxide | 1 | 2013 | 109 | 0.400 |
Why?
| | Wet Macular Degeneration | 1 | 2013 | 45 | 0.390 |
Why?
| | Animals | 18 | 2022 | 35409 | 0.380 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 756 | 0.370 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 218 | 0.360 |
Why?
| | Contrast Media | 1 | 2013 | 394 | 0.350 |
Why?
| | Anti-Inflammatory Agents | 1 | 2014 | 482 | 0.350 |
Why?
| | Nanoparticles | 1 | 2013 | 376 | 0.320 |
Why?
| | Peptides | 1 | 2013 | 926 | 0.290 |
Why?
| | Cattle | 3 | 2017 | 978 | 0.290 |
Why?
| | Mice | 8 | 2022 | 16983 | 0.270 |
Why?
| | Antiviral Agents | 1 | 2013 | 719 | 0.270 |
Why?
| | Biomimetics | 2 | 2016 | 43 | 0.250 |
Why?
| | Rats | 6 | 2019 | 5487 | 0.250 |
Why?
| | Myocytes, Cardiac | 3 | 2019 | 499 | 0.230 |
Why?
| | Laminin | 2 | 2016 | 68 | 0.230 |
Why?
| | Gelatin | 2 | 2022 | 42 | 0.230 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2014 | 196 | 0.220 |
Why?
| | Nanofibers | 2 | 2013 | 20 | 0.210 |
Why?
| | Lidocaine | 1 | 2022 | 41 | 0.200 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2045 | 0.200 |
Why?
| | Breast Neoplasms | 1 | 2013 | 2104 | 0.180 |
Why?
| | Interleukin-10 | 1 | 2022 | 304 | 0.170 |
Why?
| | Tissue Adhesives | 1 | 2020 | 17 | 0.170 |
Why?
| | Urea | 1 | 2020 | 76 | 0.160 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 89 | 0.160 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 102 | 0.160 |
Why?
| | Fetoscopy | 1 | 2018 | 26 | 0.150 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 146 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 81 | 0.150 |
Why?
| | Gold | 1 | 2019 | 119 | 0.150 |
Why?
| | Surgical Wound | 1 | 2018 | 20 | 0.150 |
Why?
| | Alginates | 1 | 2018 | 46 | 0.140 |
Why?
| | Organophosphorus Compounds | 1 | 2018 | 78 | 0.140 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 40 | 0.140 |
Why?
| | Dopamine | 1 | 2020 | 286 | 0.140 |
Why?
| | Biomedical Engineering | 1 | 2017 | 27 | 0.140 |
Why?
| | Fetus | 2 | 2021 | 782 | 0.130 |
Why?
| | Neural Tube Defects | 1 | 2017 | 58 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2013 | 2378 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 3 | 2019 | 2403 | 0.130 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 118 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 80 | 0.120 |
Why?
| | Sulfonic Acids | 1 | 2014 | 13 | 0.120 |
Why?
| | Phase Transition | 1 | 2014 | 24 | 0.120 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 21 | 0.120 |
Why?
| | Injections, Intraocular | 1 | 2014 | 10 | 0.120 |
Why?
| | Axons | 1 | 2016 | 193 | 0.110 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 81 | 0.110 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 175 | 0.110 |
Why?
| | Circular Dichroism | 1 | 2014 | 147 | 0.110 |
Why?
| | Static Electricity | 1 | 2014 | 117 | 0.110 |
Why?
| | Retina | 1 | 2016 | 283 | 0.110 |
Why?
| | Stem Cell Transplantation | 1 | 2015 | 166 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 954 | 0.110 |
Why?
| | PC12 Cells | 1 | 2013 | 40 | 0.110 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2014 | 171 | 0.110 |
Why?
| | Nerve Growth Factor | 1 | 2013 | 27 | 0.110 |
Why?
| | Lysine | 1 | 2016 | 286 | 0.110 |
Why?
| | Porosity | 1 | 2013 | 95 | 0.110 |
Why?
| | Trastuzumab | 1 | 2013 | 100 | 0.100 |
Why?
| | Polyesters | 1 | 2013 | 75 | 0.100 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 191 | 0.100 |
Why?
| | Endothelium, Corneal | 1 | 2013 | 16 | 0.100 |
Why?
| | Cell Death | 1 | 2014 | 353 | 0.100 |
Why?
| | Gram-Negative Bacteria | 1 | 2013 | 69 | 0.100 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 549 | 0.100 |
Why?
| | Surface Properties | 1 | 2013 | 400 | 0.100 |
Why?
| | Immunoassay | 1 | 2013 | 108 | 0.100 |
Why?
| | Particle Size | 1 | 2013 | 355 | 0.100 |
Why?
| | Cell Movement | 1 | 2017 | 950 | 0.100 |
Why?
| | Bevacizumab | 1 | 2013 | 128 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2017 | 4102 | 0.100 |
Why?
| | Oligopeptides | 1 | 2013 | 260 | 0.090 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 931 | 0.090 |
Why?
| | Bacteria | 1 | 2018 | 814 | 0.090 |
Why?
| | Microbial Sensitivity Tests | 1 | 2013 | 349 | 0.090 |
Why?
| | Cell Survival | 1 | 2013 | 1086 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1690 | 0.080 |
Why?
| | Ultrasonography | 1 | 2013 | 713 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2016 | 0.080 |
Why?
| | Cell Line | 1 | 2014 | 2780 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2748 | 0.080 |
Why?
| | Escherichia coli | 1 | 2013 | 766 | 0.080 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 436 | 0.080 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5468 | 0.070 |
Why?
| | Humans | 5 | 2018 | 129847 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1900 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2020 | 834 | 0.060 |
Why?
| | Female | 5 | 2021 | 68829 | 0.050 |
Why?
| | Male | 5 | 2020 | 63759 | 0.050 |
Why?
| | Pregnancy | 3 | 2021 | 6423 | 0.050 |
Why?
| | Bivalvia | 1 | 2020 | 7 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2022 | 247 | 0.040 |
Why?
| | Spinal Cord | 1 | 2021 | 355 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 845 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 224 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1441 | 0.020 |
Why?
| | Transcription Factors | 1 | 2020 | 1645 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4077 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2677 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 10241 | 0.020 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|